Abstract
Determining the penetration of drugs across the bloodbrain barrier is a significant challenge in central nervous system drug development. The use of a mechanistic physiologically based pharmacokinetic model can predict drug exposures in the brain without needing in situ drug measurements.
Original language | English |
---|---|
Pages (from-to) | 7437-7439 |
Number of pages | 3 |
Journal | Clinical Cancer Research |
Volume | 23 |
Issue number | 24 |
DOIs | |
State | Published - 15 Dec 2017 |
Externally published | Yes |